articleTop 1% cited
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
European Heart Journal · 2012 · Vol. 33(21) · pp. 2719–2747
Authors/Task Force Members✉A. John Camm(St George's, University of London)Gregory Y.H. LipRaffaele De CaterinaIrene SavelievaDan AtarStefan H. HohnloserGerhard HindricksPaulus KirchhofJeroen J. BaxHelmut BaumgartnerClaudio CeconiVerónica DeanChristi DeatonRobert FagardChristian Funck‐BrentanoDavid HasdaiArno W. HoesPaulus KirchhofJuhani KnuutiPhilippe KolhTheresa A. McDonaghCyril MoulinBogdan A. PopescuŽeljko ReinerUdo SechtemPer Anton SirnesMichal TenderaAdam TorbickiAlec VahanianStephan WindeckerDocument ReviewersPanos VardasNawwar Al-AttarOttavio AlfieriAnnalisa AngeliniCarina Blömstrom-LundqvistPaolo ColonnaJohan De SutterSabine ErnstAndreas GoetteBülent GörenekRóbert Hatala(Aarhus University Hospital)Hein HeidbüchelMagnus HeldalSteen Dalby KristensenPhilippe KolhJean‐Yves Le HeuzeyHercules E. MavrakisLluı́s MontPasquale Perrone FilardiPiotr PonikowskiBernard PrendergastFrans H. RuttenUlrich SchottenIsabelle C. Van GelderFreek W.A. Verheugt
Abstract
Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsHealth Systems, Economic Evaluations, Quality of LifeMedicineAtrial fibrillationManagement of atrial fibrillationIntensive care medicineCardiology
MeSH terms
Anti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationElectric CountershockHeart FailureHemorrhageHumansThromboembolismCatheter AblationRisk AssessmentAtrial AppendageStrokeEarly DiagnosisTherapeutic Occlusion
Citations
2,889
FWCI
238.33
field-weighted impact
References
203
Percentile
100%
vs. same field & year
Citations per year
Cited by
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Heart · 2014 · 609 citations
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Circulation · 2014 · 7,136 citations
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
European Heart Journal · 2014 · 1,651 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · 13,652 citations
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
Thrombosis and Haemostasis · 2013 · 364 citations
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
European Heart Journal · 2013 · 3,335 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Journal of Hypertension · 2013 · 5,659 citations
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
Thrombosis and Haemostasis · 2014 · 459 citations
References
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
Thrombosis and Haemostasis · 2012 · 502 citations
Validation of Clinical Classification Schemes for Predicting Stroke
JAMA · 2001 · 4,834 citations
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
Thrombosis and Haemostasis · 2012 · 489 citations
Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
Thrombosis and Haemostasis · 2008 · 369 citations
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
New England Journal of Medicine · 2011 · 9,320 citations
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Thrombosis and Haemostasis · 2010 · 1,372 citations
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
American Heart Journal · 2006 · 996 citations
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2012 · 918 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
